Twist Bioscience Corp (TWST) has released an update to notify the public and investors about the submission of matters to a vote of security holders.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
At Twist Bioscience Corporation’s 2024 Annual Meeting, over 90% of eligible shareholders participated to make key decisions. Two Class III directors were elected to the Board, with Emily M. Leproust, Ph.D., and Robert Chess securing their positions by a notable margin. The executive compensation package received a majority approval in a non-binding advisory vote. Additionally, Ernst & Young LLP was ratified as the company’s independent accounting firm for the upcoming fiscal year, showcasing strong shareholder confidence in the company’s governance and financial oversight.
For further insights into TWST corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.
